{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:30:50Z","timestamp":1791952250919,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.biologicals.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T07:58:35Z","timestamp":1570780715000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB\/c mice"],"prefix":"10.1016","volume":"62","author":[{"given":"Sharif","family":"Maraghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ata A.","family":"Ghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Tavalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeedeh","family":"Shojaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman","family":"Abdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12\u201313","key":"10.1016\/j.biologicals.2019.10.002_bib1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.biologicals.2019.10.002_bib2","series-title":"Toxoplasma gondii","first-page":"193","article-title":"Chapter 6 - toxoplasmosis in wild and domestic animals","author":"Lindsay","year":"2014"},{"issue":"452","key":"10.1016\/j.biologicals.2019.10.002_bib3","article-title":"Fever and lymphadenopathy: acute toxoplasmosis in an immunocompetent patient","volume":"10","author":"Kaparos","year":"2014","journal-title":"Rev Med Suisse"},{"issue":"3","key":"10.1016\/j.biologicals.2019.10.002_bib4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.actatropica.2013.05.006","article-title":"Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients","volume":"127","author":"Yan","year":"2013","journal-title":"Acta Trop"},{"issue":"2","key":"10.1016\/j.biologicals.2019.10.002_bib5","first-page":"59","article-title":"Toxoplasmosis in immunocompromised patients","volume":"64","author":"Machala","year":"2015","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"10.1016\/j.biologicals.2019.10.002_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fmicb.2014.00385","article-title":"Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon","volume":"5","author":"Oz","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biologicals.2019.10.002_bib7","article-title":"Cloning and expression of major surface antigen 1 gene of Toxoplasma gondii RH strain using the expression vector pVAX1 in Chinese hamster ovary cells","volume":"8","author":"Abdizadeh","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.biologicals.2019.10.002_bib8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","article-title":"Vaccines against Toxoplasma gondii: new developments and perspectives","volume":"12","author":"Zhang","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2019.10.002_bib9","first-page":"23","article-title":"Current progress toward vaccines against Toxoplasma gondii. Vaccine","volume":"4","author":"Garcia","year":"2014","journal-title":"Dev Therapy"},{"key":"10.1016\/j.biologicals.2019.10.002_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2019.8.1.4","article-title":"Rhoptry antigens as Toxoplasma gondii vaccine target","volume":"8","author":"Foroutan","year":"2019","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.biologicals.2019.10.002_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10096-018-03442-6","article-title":"A systematic review on efficiency of microneme proteins to induce protective immunity against Toxoplasma gondii","volume":"38","author":"Dodangeh","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.biologicals.2019.10.002_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.micpath.2018.11.003","article-title":"A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization","volume":"126","author":"Rezaei","year":"2019","journal-title":"Microb Pathog"},{"issue":"10","key":"10.1016\/j.biologicals.2019.10.002_bib13","first-page":"4576","article-title":"Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens","volume":"9","author":"Tomavo","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biologicals.2019.10.002_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0020-7519(95)00103-4","article-title":"Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion","volume":"26","author":"Grimwood","year":"1996","journal-title":"Int J Parasitol"},{"issue":"1","key":"10.1016\/j.biologicals.2019.10.002_bib15","first-page":"167","article-title":"An overview of immunologic adjuvants-A review","volume":"4","author":"Aiyer Harini","year":"2013","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.biologicals.2019.10.002_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/vaccines2020252","article-title":"Adjuvants in the driver's seat: how magnitude, type, fine specificity and longevity of immune responses are driven by distinct classes of immune potentiators","volume":"2","author":"Bergmann-Leitner","year":"2014","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.biologicals.2019.10.002_bib17","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.4049\/jimmunol.175.6.3882","article-title":"Activation of innate immunity, inflammation, and potentiation of DNA vaccination through mammalian expression of the TLR5 agonist flagellin","volume":"175","author":"Applequist","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.biologicals.2019.10.002_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.biologicals.2019.10.002_bib19","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/IAI.72.5.2810-2816.2004","article-title":"Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses","volume":"72","author":"Cuadros","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.biologicals.2019.10.002_bib20","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","article-title":"Flagellin as an adjuvant: cellular mechanisms and potential","volume":"185","author":"Mizel","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.biologicals.2019.10.002_bib21","first-page":"114","article-title":"An insight into the behavior, course and kinetics of acute infection of Toxoplasma gondii human RH strain in experimentally infected murine model","volume":"9","author":"Sudan","year":"2014","journal-title":"Iran J Parasitol"},{"key":"10.1016\/j.biologicals.2019.10.002_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biologicals.2019.10.002_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1756-3305-6-175","article-title":"Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis","volume":"6","author":"Zhao","year":"2013","journal-title":"Parasites Vectors"},{"issue":"9","key":"10.1016\/j.biologicals.2019.10.002_bib24","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.biologicals.2019.10.002_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1046-2023(03)00140-3","article-title":"Adjuvant formulations and delivery systems for DNA vaccines","volume":"31","author":"Sasaki","year":"2003","journal-title":"Methods"},{"key":"10.1016\/j.biologicals.2019.10.002_bib26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14760584.2015.1011133","article-title":"DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA1 induces protective immunity against toxoplasmosis in Kunming mice","volume":"14","author":"Chen","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"17","key":"10.1016\/j.biologicals.2019.10.002_bib27","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.vaccine.2015.03.006","article-title":"Salmonella flagellin is a potent carrier\u2013 adjuvant for peptide conjugate to induce peptide-specific antibody response in mice","volume":"33","author":"Qian","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biologicals.2019.10.002_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148701","article-title":"Flagellin encoded in gene-based vector vaccines is a route-dependent immune adjuvant","volume":"11","author":"Rady","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2019.10.002_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3923\/jms.2007.361.367","article-title":"Enhancement of antibody immune response to a Toxoplasma gondii SAGl\u2014 encoded DNA vaccine by formulation with aluminum phosphate","volume":"7","author":"Far","year":"2007","journal-title":"J Med Sci"},{"issue":"1","key":"10.1016\/j.biologicals.2019.10.002_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00436-012-2852-7","article-title":"Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii","volume":"111","author":"Khosroshahi","year":"2012","journal-title":"Parasitol Res"},{"issue":"4","key":"10.1016\/j.biologicals.2019.10.002_bib31","first-page":"590","article-title":"Evaluation of immunogenicity of cocktail DNA vaccine containing plasmids encoding complete GRA5, SAG1, and ROP2 antigens of Toxoplasma gondii in BALB\/C mice","volume":"10","author":"Naserifar","year":"2015","journal-title":"Iran J Parasitol"},{"key":"10.1016\/j.biologicals.2019.10.002_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/1471-2334-13-494","article-title":"DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB\/c mice","volume":"13","author":"Meng","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.biologicals.2019.10.002_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/315186","article-title":"Immunization with a DNA plasmid encoding the SAG1(P30) protein of Toxoplasma gondii is immunogenic and protective in rodents","volume":"181","author":"Angus","year":"2000","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.biologicals.2019.10.002_bib34","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0264-410X(98)00039-5","article-title":"Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii","volume":"16","author":"Petersen","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.10.002_bib35","first-page":"1","article-title":"Toxoplasma gondii recombinant surface antigen (SAG 1; P 30) and its applications in serodiagnosis and vaccine development for toxoplasmosis","volume":"6","author":"Abdullah","year":"2010","journal-title":"Malays J Med Health Sci"},{"issue":"15\u201316","key":"10.1016\/j.biologicals.2019.10.002_bib36","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0264-410X(98)00463-0","article-title":"Salbutamol as an adjuvant for nasal vaccination","volume":"17","author":"Fermin","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biologicals.2019.10.002_bib37","first-page":"268","article-title":"Recombinant SAG1 antigen-loaded PLGA microspheres as a novel vaccine delivery system against Toxoplasma gondii","volume":"7","author":"Allahyari","year":"2012","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.biologicals.2019.10.002_bib38","unstructured":"Abasi E, Shahabi S, Golkar M, Khezri P, Mohammadzadeh H, Urmia I. Evaluation of immunogenic effect of Toxoplasma gondii recombinant SAG-1 antigen with propranolol as adjuvant in BALB\/c mice. Adv Pharmaceut Bull, in press."},{"key":"10.1016\/j.biologicals.2019.10.002_bib39","first-page":"1005","article-title":"Recombinant subunit vaccines against Toxoplasma gondii: successful experimental trials using recombinant DNA and proteins in mice in a period from 2006 to 2018","volume":"1","author":"Fereig","year":"2018","journal-title":"J Vet Med Anim Sci"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105619301083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105619301083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:14Z","timestamp":1760922854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105619301083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":39,"alternative-id":["S1045105619301083"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.10.002","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}